Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V-101 Cream dose-response in erythematous rosacea
NCT01186068Phase 2Completed
- Sponsor
- Vicept Therapeutics
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mucinex Full Force Nasal Spray in Erythematotelangiectatic Rosacea (ETR), sponsored by Vicept Therapeutics. Started Aug 2010; status: completed.
02
Drugs
Mucinex Full Force Nasal Spray
03
Conditions
Erythematotelangiectatic Rosacea (ETR)
Beyond the preview
Go deeper on NCT01186068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01186068.